| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2005;80:511-517
© 2005 The Society of Thoracic Surgeons
a Department of Anesthesiology, Division of Intensive Care, University of Oulu, Oulu, Finland
b Department of Internal Medicine, University of Oulu, Oulu, Finland
c Department of Surgery, University of Oulu, Oulu, Finland
Accepted for publication March 4, 2005.
* Address reprint requests to Dr Koskenkari, Department of Anesthesiology, Box 21, Oulu FIN-90029, Finland (Email: juha.koskenkari{at}fimnet.fi).
BACKGROUND: Glucose and insulin have been used as an adjuvant therapy in cardiac surgery because of their potentially beneficial effects on myocardial metabolism and contractile function. This study evaluated the effects of high-dose insulin on systemic metabolism and hemodynamics after combined heart surgery.
METHODS: Forty elective patients scheduled for combined aortic valve replacement and coronary artery bypass surgery were randomly assigned to receive either high-dose insulin treatment (short-acting insulin 1 IU·kg–1 ·h–1 with 30% glucose 1.5 mL·kg–1 ·h–1 administered separately) or control treatment (saline). The blood glucose levels were maintained within a targeted range by adjusting the rate of glucose infusion in the treatment group and by short-acting insulin bolus doses in the control group.
RESULTS: The lactate clearance was faster (p = 0.046), and the lactate levels (p = 0.016), blood glucose levels (p < 0.001), and free fatty acid levels (p < 0.001) were lower in the insulin group postoperatively. Besides, there was lesser need for dobutamine support (p = 0.013) and a trend toward better cardiac indices. Insulin treatment increased the respiratory quotient (p < 0.001), but there were no differences between the groups with regard to systemic oxygen consumption or energy expenditure measured by indirect calorimetry. The average glucose uptake in the insulin group was 7.1 g/kg in 24 hours (28 kcal·kg–1 ·day–1).
CONCLUSIONS: The high-dose insulin treatment was associated with lower blood glucose levels, better preserved myocardial contractile function, and less need for inotropic support, and hence led to lower lactate levels postoperatively. The protocol is safe, but requires strict control of blood glucose level.
This article has been cited by other articles:
|
|
 |
|
  S. Akhtar, P. G. Barash, and S. E. Inzucchi Scientific Principles and Clinical Implications of Perioperative Glucose Regulation and Control Anesth. Analg., February 1, 2010; 110(2): 478 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Puskarich, M. S. Runyon, S. Trzeciak, J. A. Kline, and A. E. Jones Effect of Glucose-Insulin-Potassium Infusion on Mortality in Critical Care Settings: A Systematic Review and Meta-Analysis J. Clin. Pharmacol., July 1, 2009; 49(7): 758 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Y. Gandhi, M. H. Murad, D. N. Flynn, P. J. Erwin, A. B. Cavalcante, H. B. Nielsen, S. E. Capes, K. Thorlund, V. M. Montori, and P. J. Devereaux Effect of Perioperative Insulin Infusion on Surgical Morbidity and Mortality: Systematic Review and Meta-analysis of Randomized Trials Mayo Clin. Proc., April 1, 2008; 83(4): 418 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ellger, Y. Debaveye, I. Vanhorebeek, L. Langouche, A. Giulietti, E. Van Etten, P. Herijgers, C. Mathieu, and G. Van den Berghe Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes, April 1, 2006; 55(4): 1096 - 1105. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
